PeptiSystems partners with ATG Service to expand North American support
PeptiSystems AB, a leading innovator in flowthrough peptide and oligonucleotide synthesis technology, is thrilled to announce a strategic partnership with ATG Service, a premier provider of technical support and maintenance services. This collaboration aims to enhance the installation, service, and support for PeptiSystems' flagship products, PeptiPilot® and OligoNavigator® synthesizers, across North America.
With a strong reputation for high-quality and reliable synthesis equipment, PeptiSystems continues to push the boundaries in solid-phase synthesis of new drug modalities. The PeptiPilot and OligoNavigator synthesizers are revolutionizing peptide and oligonucleotide production, offering PMI reduction with improved purity and yield and shorter synthesis times.
ATG Service, renowned for its extensive network and exceptional service standards, brings 22 highly skilled Service Engineers strategically located throughout North America to this partnership. This collaboration ensures that customers benefit from prompt, professional, and reliable installation and ongoing support for PeptiSystems' advanced synthesizers.
"We are extremely enthusiastic about the partnership with ATG Service,” said Karin Granath, CEO of PeptiSystems. “Their expertise and nationwide presence align perfectly with our commitment to delivering superior technology and exceptional customer care. We couldn't expect a better partner to support us in our strategy to maintain high customer satisfaction. The collaboration with ATG Service will allow PeptiSystems to develop even faster in the US and Canadian markets."
The partnership will leverage ATG Service's extensive experience in technical support to ensure that PeptiSystems' customers receive timely and efficient service. The Service Engineers are equipped with comprehensive training on the PeptiPilot and OligoNavigator synthesizers, ensuring they can address any technical issues swiftly and effectively.
“PeptiSystems’ dedication to manufacturing high-quality, reliable oligonucleotide and peptide synthesizers is consistent with ATG Service’s own commitment to maximize our customers’ uptime with best-in-class service in full alignment with our customers’ interests,” said John Nalley, COO of ATG Service.
This collaboration marks a significant step forward in PeptiSystems' mission to provide cutting-edge synthesis solutions supported by an unparalleled customer service experience. Customers can expect a seamless transition during installation and continuous, responsive support throughout the lifecycle of their synthesizers.
For more information, please contact:
Karin Granath, CEO
Phone: +46 702-82 07 47
Email: karin.granath@peptisystems.com
About PeptiSystems AB
PeptiSystems is a biotech company developing a new generation of flow-through instruments for peptide and oligonucleotide therapeutics synthesis. Utilizing proprietary flow-through column technology, PeptiSystems' instruments significantly reduce production times, enhance synthesis control, and minimize raw material consumption while maintaining high purity and yield. With scalability in mind, these next-generation synthesis instruments seamlessly adapt from small-scale development to large-scale production, enabling pharmaceutical companies and CDMOs to meet the growing global demand for high-performance, cost-effective, and sustainable manufacturing processes. PeptiSystems is headquartered in Uppsala, Sweden. For more information, please visit www.peptisystems.com and follow us on LinkedIn.